We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

Gabapentin Treatment for Alcohol Dependence

Benjamin P. Geisler, MD, MPH1; Arnab Ghosh, MD, MA1
[+] Author Affiliations
1Department of Medicine, NYU School of Medicine, New York, New York
JAMA Intern Med. 2014;174(7):1201. doi:10.1001/jamainternmed.2014.1618.
Text Size: A A A
Published online


To the Editor New treatments—both pharmacologic and nonpharmacologic—for one of the most devastating substance abuse disorders, alcoholism, are direly needed. We were therefore delighted to read an article reporting on a trial of gabapentin as a treatment option for alcohol dependence.1 Unfortunately, this article does not clarify whether gabapentin increases the proportion of abstinent patients or those without heavy drinking. While the research protocol had stipulated a sample size of 150 patients randomized to 1 treatment and 1 placebo control group, the same number of patients was split among 3 groups: 2 active treatment and 1 placebo control group (clinicaltrials.gov identifier: NCT00391716). The authors calculated their sample size based on an acamprosate trial from a different setting.2 Consequently, it seems that the odds ratio for one of the co-primary end points, abstinence, compares the higher dosage group, gabapentin 1800 mg/d, with placebo and was not statistically different (odds ratio, 4.8; 95% CI, 0.9-35.0). This fact is obscured by the article’s focus on a linear dose effect, with a P value below .05 from an extended Mantel-Haenszel χ2 test for linear association. In contrast, no P values were reported for the prespecified analysis. We believe that outcomes should not be selectively reported, and clinical trials should either adhere to their preregistered protocol or explain why they differed from it. Therefore, this present trial should be regarded as a dose-ranging study but not as a pivotal trial, which provides proof with traditional frequentist inference.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





July 1, 2014
Barbara J. Mason, PhD; Vivian Goodell, MPH; Farhad Shadan, MD, PhD
1The Scripps Research Institute, Pearson Center for Alcoholism and Addiction, Research, La Jolla, California
1The Scripps Research Institute, Pearson Center for Alcoholism and Addiction, Research, La Jolla, California2Scripps Clinic and Scripps Green Hospital, La Jolla, California
JAMA Intern Med. 2014;174(7):1201-1202. doi:10.1001/jamainternmed.2014.1591.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...